NCT03128736View on ClinicalTrials.gov

Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B

PHASE4CompletedINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

February 28, 2016

Study Completion Date

March 30, 2016

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Esomeprazole group

Esomeprazole 40mg qd

DRUG

Dexlansoprazole group

Dexlansoprazole 60mg qd

All Listed Sponsors

lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT03128736 - Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B | Biotech Hunter | Biotech Hunter